Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2550
Source ID: NCT00256646
Associated Drug: Rosiglitazone
Title: Markers and Mechanisms of Vascular Disease in Type II Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG: Rosiglitazone
Outcome Measures: Primary: The primary outcome measure is to define these unique processes and to elucidate underlying biochemical, metabolic, and genetic determinants of vascular disease complications in diabetes., 2, 4, and 6 years. |
Sponsor/Collaborators: Sponsor: US Department of Veterans Affairs | Collaborators: American Diabetes Association
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 298
Study Type: OBSERVATIONAL
Study Designs: Observational Model: |Time Perspective: p
Start Date: 2007-06
Completion Date: 2008-05
Results First Posted:
Last Update Posted: 2014-05-23
Locations: Carl T. Hayden VA Medical Center, Phoenix, Arizona, 85012, United States|Southern Arizona VA Health Care System, Tucson, Tucson, Arizona, 85723, United States|VA Central California Health Care System, Fresno, Fresno, California, 93703, United States|VA Medical Center, Long Beach, Long Beach, California, 90822, United States|VA San Diego Healthcare System, San Diego, San Diego, California, 92161, United States|Miami VA Healthcare System, Miami, FL, Miami, Florida, 33125, United States|Edward Hines, Jr. VA Hospital, Hines, Illinois, 60141-5000, United States|Richard Roudebush VA Medical Center, Indianapolis, Indianapolis, Indiana, 46202-2884, United States|VA Medical Center, Lexington, Lexington, Kentucky, 40502, United States|VA Medical Center, Minneapolis, Minneapolis, Minnesota, 55417, United States|VA Medical Center, Omaha, Omaha, Nebraska, 68105-1873, United States|VA New Jersey Health Care System, East Orange, East Orange, New Jersey, 07018, United States|VA Pittsburgh Health Care System, Pittsburgh, Pennsylvania, 15240, United States|Michael E. DeBakey VA Medical Center (152), Houston, Texas, 77030, United States|VA South Texas Health Care System, San Antonio, San Antonio, Texas, 78229, United States|VA Medical Center, Salem VA, Salem, Virginia, 24153, United States|VA Medical Center, San Juan, San Juan, 00921, Puerto Rico
URL: https://clinicaltrials.gov/show/NCT00256646

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D116 Rosiglitazone small molecule DB00412 Details